Bioinformatics Analysis on Molecular Mechanism of Maxing Shigan Decoction in Treating H1N1 Influenza A

LI Li; ZHAO Jing; WANG Xue-fei; TAN Yong; JIANG Miao; LV Cheng; LV Ai-ping

doi:10.11653/syfj2013130346

您当前的位置：

首页 >

文章列表页 >

Bioinformatics Analysis on Molecular Mechanism of Maxing Shigan Decoction in Treating H1N1 Influenza A

更新时间：2024-01-04

- Bioinformatics Analysis on Molecular Mechanism of Maxing Shigan Decoction in Treating H1N1 Influenza A
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 19, Issue 13, Pages: 346-350(2013)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.11653/syfj2013130346
  CLC：
- Published：2013
- 稿件说明：
移动端阅览
LI Li, ZHAO Jing, WANG Xue-fei, et al. Bioinformatics Analysis on Molecular Mechanism of Maxing Shigan Decoction in Treating H1N1 Influenza A[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(13): 346-350.
DOI：

LI Li, ZHAO Jing, WANG Xue-fei, et al. Bioinformatics Analysis on Molecular Mechanism of Maxing Shigan Decoction in Treating H1N1 Influenza A[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(13): 346-350. DOI： 10.11653/syfj2013130346.

摘要

目的: 通过构建分子网络及解析生物学通路

探讨麻杏石甘汤防治甲型H1N1流感的分子机制。方法: 查找麻杏石甘汤中药成分的有效化合物

在PubChem数据库中检索有效成分的靶蛋白

在Gene数据库中查找甲型H1N1流感的相关基因

运用Ingenuity Pathway Analysis (IPA)软件对二者进行构图和解析。结果: 查找到麻杏石甘汤的靶蛋白186个

甲型H1N1流感相关基因7个。二者的分子网络复杂

生物功能多样

在共同作用的8条生物通路中

有4条通路为细胞免疫相关通路:病毒模式识别受体信号通路、巨噬细胞白介素12(IL-12)信号和生产通路、蛋白激酶(PKR)在干扰素诱导的抗病毒反应中作用通路、肿瘤坏死因子受体I (TNFR1)信号通路。麻杏石甘汤可以调节细胞免疫相关通路中的Toll样受体9(TLR9)、磷脂酰肌醇3-激酶(PI3K)、核苷酸结合的寡聚结构域2受体(NOD2)等多个位点。结论: 麻杏石甘汤可以通过干预细胞免疫相关通路中的多个位点起到防治甲型H1N1流感的作用。

Abstract

Objective:To study the molecular mechanism of Maxing Shigan decoction in the treatment of H1N1 influenza A:by establishing molecular networks and comparing canonical pathways. Method: Target proteins of Maxing Shigan decoction and related genes of H1N1 influenza A were searched based on Pubchem and Gene databases on line. Molecular networks and canonical pathways comparison analyses were performed by Ingenuity pathway Analysis(IPA). Result: There were 186 targets proteins of Maxing Shigan decoction and 7 related genes of H1N1 influenza A. The molecular networks of Maxing Shigan decoction and H1N1 influenza A were multifunction. There were four cellular immune related pathways in all eight common pathways including:role of pattern recognition receptors in recognition of viruses

interlewkin 12(IL-12) signaling and production in macrophages

role of proten kinase(PKR) in interferon induction and antiviral response and Tumor necrosis factor receptor 1(TNFR1) signaling.Maxing Shigan decoction could regulate Toll-like receptor(TLR9)

phosphoinostide 3 -kinase(PI3K)

nucleotide-binding oligomerization domain 2(NOD2) and other molecules of cellular immune related pathways. Conclusion: Regulating many effective nodes of cellular immune related pathways maybe the way of Maxing Shigan decoction against H1N1 influenza A.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Anti-asthmatic Effects of Maxing Shigan Decoction Based on Biological Signal Acquisition and Processing System

Effects of Different Boiling Methods of Maxing Shigan Decoction on Acute Hypoxia Environment and Mucus Secretion in Airway of Asthmatic Model Mice

Research of Dose-effect Relationship of Maxin Shigan Decoction with the Dosage Changes of Gypsum Fibrosurn

Related Author

YU Ri-yue

LI Wen-hong

JING Sheng-long

TONG Wen-ting

XU Peng

XU Guo-liang

LI Zuo-yong

LIU Bo

Related Institution

First Clinical Medical College of Three Gorges University

College of Pharmacy,Jiangxi University of Traditional Chinese Medicine

江西中医学院现代中药制剂教育部重点实验室

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰